Using the MDA-MB-231 orthotopic mouse model, we treated tumor-bearing mice with vehicle, palbociclib, an AURKA inhibitor (alisertib), or the combination of palbociclib and alisertib. This evidence concerns the gene AURKA and neoplasm.